Physician profile
Chase Knickerbocker
NPI 1982090536
$1,171.49
in general payments reported to CMS, 2019-2025
10 companies · $20.00 in 2025
The $20.00 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $29.24 · 2022: $727 · 2023: $141 · 2024: $125 · 2025: $20.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $125 · Food and Beverage: $111 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $125.21 |
| Food and Beverage | $110.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $799.08 | 2022-2025 | |
| Portola Pharmaceuticals, LLC | $129.98 | 2020 | |
| Becton, Dickinson and Company | $50.00 | 2023 | Bd Safetyglide |
| Csl Behring | $49.78 | 2022-2023 | Kcentra |
| Conmed Corporation | $41.67 | 2022 | |
| Kerecis Limited | $25.35 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Melinta Therapeutics, LLC | $23.93 | 2023 | Rezzayo, Vabomere |
| Shionogi INC | $22.46 | 2023 | Fetroja |
| Alexion Pharmaceuticals, INC. | $15.44 | 2021 | |
| Merck Sharp & Dohme LLC | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Knickerbocker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.